https://seekingalpha.com/article/4592603-biogen-and-eisai-cassava-sciences-and-anavex-clinical-trial-results-in-need-of-revisions
Biogen And Eisai, Cassava Sciences, And Anavex: Clinical Trial Results In Need Of Revisions
Apr. 06, 2023 6:28 AM ET
Summary
Biogen And Eisai, Cassava Sciences, And Anavex: Clinical Trial Results In Need Of Revisions
Apr. 06, 2023 6:28 AM ET
Summary
- Biogen and Eisa compared the effects of their drug Leqembi against the combined placebo decline rather than against the different rates of decline for APOE4 carriers and non-carriers.
- This made Leqembi look more effective for non-carriers than it actually was while making APOE4 homozygotes look like they were actually getting worse on the drug compared to the placebo.